SOLVENTUM CORPORATION Share-based Payment Arrangement, Expense, Tax Benefit
SOLVENTUM CORPORATION (SOLV) reported Share-based Payment Arrangement, Expense, Tax Benefit of $7.00 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Expense Statement › Income Tax
us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense · last filed 2026-08-05
- SOLVENTUM CORPORATION share-based payment arrangement, expense, tax benefit for the quarter ending 2026-06-30 was $7.00M, a 16.67% increase year-over-year.
- SOLVENTUM CORPORATION share-based payment arrangement, expense, tax benefit for the quarter ending 2026-03-31 was $9.00M, a 80.00% increase year-over-year.
- SOLVENTUM CORPORATION share-based payment arrangement, expense, tax benefit for the quarter ending 2025-12-31 was $5.00M, a 0.00% change year-over-year.
- SOLVENTUM CORPORATION share-based payment arrangement, expense, tax benefit for the quarter ending 2025-09-30 was $6.00M, a 20.00% increase year-over-year.
- SOLVENTUM CORPORATION share-based payment arrangement, expense, tax benefit for fiscal 2025 was $22.00M, a 22.22% increase from fiscal 2024.
- SOLVENTUM CORPORATION share-based payment arrangement, expense, tax benefit for fiscal 2024 was $18.00M, a 100.00% increase from fiscal 2023.
- SOLVENTUM CORPORATION share-based payment arrangement, expense, tax benefit for fiscal 2023 was $9.00M, a 0.00% change from fiscal 2022.
- SOLVENTUM CORPORATION share-based payment arrangement, expense, tax benefit for fiscal 2022 was $9.00M.
| Period end | Share-based Payment Arrangement, Expense, Tax Benefit 3 month | Share-based Payment Arrangement, Expense, Tax Benefit 6 month | Share-based Payment Arrangement, Expense, Tax Benefit 9 month | Share-based Payment Arrangement, Expense, Tax Benefit 12 month |
|---|---|---|---|---|
| 2026-06-30 | $7.00M 10-Q · filed 2026-08-05 | $16.00M 10-Q · filed 2026-08-05 | $21.00M derived: sum of 3 quarters · filed 2026-08-05 | $27.00M derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | $9.00M 10-Q · filed 2026-05-05 | $14.00M derived: sum of 2 quarters · filed 2026-05-05 | $20.00M derived: sum of 3 quarters · filed 2026-05-05 | $26.00M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | $5.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $11.00M derived: sum of 2 quarters · filed 2026-02-27 | $17.00M derived: sum of 3 quarters · filed 2026-08-05 | $22.00M 10-K · filed 2026-02-27 |
| 2025-09-30 | $6.00M 10-Q · filed 2025-11-06 | $12.00M derived: sum of 2 quarters · filed 2026-08-05 | $17.00M 10-Q · filed 2025-11-06 | $22.00M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | $6.00M 10-Q · filed 2026-08-05 | $11.00M 10-Q · filed 2026-08-05 | $16.00M derived: sum of 3 quarters · filed 2026-08-05 | $21.00M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | $5.00M 10-Q · filed 2026-05-05 | $10.00M derived: sum of 2 quarters · filed 2026-05-05 | $15.00M derived: sum of 3 quarters · filed 2026-05-05 | $25.00M derived: sum of 4 quarters · filed 2026-05-05 |
| 2024-12-31 | $5.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $10.00M derived: sum of 2 quarters · filed 2026-02-27 | $20.00M derived: sum of 3 quarters · filed 2026-02-27 | $18.00M 10-K · filed 2026-02-27 |
| 2024-09-30 | $5.00M 10-Q · filed 2025-11-06 | $15.00M derived: sum of 2 quarters · filed 2025-11-06 | $13.00M 10-Q · filed 2025-11-06 | $14.00M derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-06-30 | $10.00M 10-Q · filed 2025-08-08 | $8.00M 10-Q · filed 2025-08-08 | $9.00M derived: sum of 3 quarters · filed 2026-02-27 | $11.00M derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-03-31 | -$2.00M 10-Q · filed 2025-05-09 | -$1.00M derived: sum of 2 quarters · filed 2026-02-27 | $1.00M derived: sum of 3 quarters · filed 2026-02-27 | $3.00M derived: sum of 4 quarters · filed 2026-02-27 |
| 2023-12-31 | $1.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $3.00M derived: sum of 2 quarters · filed 2026-02-27 | $5.00M derived: sum of 3 quarters · filed 2026-02-27 | $9.00M 10-K · filed 2026-02-27 |
| 2023-09-30 | $2.00M 10-Q · filed 2024-11-08 | $4.00M derived: sum of 2 quarters · filed 2024-11-08 | $8.00M 10-Q · filed 2024-11-08 | |
| 2023-06-30 | $2.00M 10-Q · filed 2024-08-09 | $6.00M 10-Q · filed 2024-08-09 | ||
| 2022-12-31 | $9.00M 10-K · filed 2025-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| Heartflow, Inc. (HTFL) | United States | $4.225B |